Institutional investors hold a majority ownership of MRK through the 75.69% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HANDELSBANKEN FONDER AB Bought 935.5 Thousand shares of Merck
KLP KAPITALFORVALTNING AS Bought 457.3 Thousand shares of Merck
LPL FINANCIAL LLC Bought 401.5 Thousand shares of Merck